Extracellular vesicles (EVs) are a highly heterogeneous population of membranous particles that are secreted by almost all types of cells across different domains of life, including plants. In recent years, studies on plant-derived nanovesicles (PDNVs) showed that they could modulate metabolic reactions of the recipient cells, affecting (patho)physiology with health benefits in a trans-kingdom manner. In addition to its bioactivity, PDNV has advantages over conventional nanocarriers, making its application promising for therapeutics delivery. Here, we discuss the characteristics of PDNV and highlight up-to-date pre-clinical and clinical evidence, focusing on therapeutic application.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9319657 | PMC |
| http://dx.doi.org/10.3390/cells11142232 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Isolation and characterization of medicinal plant-based extracellular vesicles as nano delivery systems for ascorbic acid.
J Microencapsul
December 2024
Department of Biochemistry and Molecular Biology, Usmanu Danfodiyo University, Sokoto, Nigeria.
Aim: Plant-derived extracellular vesicles (EVs) are natural nanovesicles for drug delivery. This study isolated and characterised EVs from medicinal plants as delivery vehicles.
Methods: Precipitation method was employed for the isolation and characterised using DLS, SEM, and TEM.
Extracellular Vesicle-Like Nanovesicle for Skin Photoaging Therapy.
Biomater Res
December 2024
Center for Plastic & Reconstructive Surgery, Department of Dermatology, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, Zhejiang 310014, China.
Ultraviolet (UV) irradiation leads to the degradation of the extracellular matrix and collagen, thereby accelerating skin aging and imposing substantial psychological burden on patients. Current anti-aging strategies are limited and often associated with high costs or strong side effects. Plant-derived extracellular vesicle-like nanovesicles, with advantages such as natural availability and cost-effectiveness, show potential in anti-aging interventions.
View Article and Find Full Text PDFMetabolomic analysis of plant-derived nanovesicles and extracellular vesicles from Pinellia ternata: insights into a temporary immersion bioreactor system.
Physiol Plant
December 2024
School of Biotechnology and Pharmaceutical Engineering, Nanjing Tech University, Nanjing, Jiangsu, China.
Plant-derived nanovesicles (PDNVs) and extracellular vesicles (EVs) represent a promising area of research due to their unique properties and potential therapeutic applications. Pinellia ternata (P. ternata) is well-known for its pharmacological properties but the PDNVs and EVs derived from it have been largely understudied.
View Article and Find Full Text PDFderived exosome-like nanovesicles alleviate restenosis after vascular injury through the Keap1/Nrf2 pathway.
Food Funct
December 2024
Department of Heart Center, The Third Central Hospital of, Tianjin, 300170, China.
Despite the significant alleviation of clinical cardiovascular diseases through appropriate interventional treatments, the recurrence of vascular restenosis necessitating reoperation remains a substantial challenge impacting patient prognosis. Plant-derived exosome-like nanovesicles (PELNs) are integral to interspecies cellular communication, with their functions and potential applications garnering significant attention from the research community. This study extracted -derived exosome-like nanovesicles (SL-ELNs) and demonstrated their inhibition of PDGF-BB-induced proliferation, migration, and phenotypic transformation of vascular smooth muscle cells (VSMCs).
View Article and Find Full Text PDFIncorporation of doxorubicin into plant-derived nanovesicles: process monitoring and activity assessment.
Drug Deliv
December 2025
Department of Toxicology, Faculty of Pharmacy, Medical University of Gdansk, Gdansk, Poland.
Extracellular vesicles (EVs) are an experimental class of drug carriers. Alternative sources of EVs are currently being explored to overcome limitations related to their manufacturing from mesenchymal stem cells. In this work, derived EVs were tested as carriers for the widely used chemotherapeutic drug - doxorubicin (DOX).
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!